BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37014402)

  • 1. Tectoridin and PLK1 inhibitor synergistically promote the apoptosis of lung adenocarcinoma cells: Bioinformatic analysis of TCGA and TCMSP.
    Wang M; Zhao F; Li Z; Li X; Dong L
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Oct; 396(10):2417-2426. PubMed ID: 37014402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DLGAP5 promotes lung adenocarcinoma growth via upregulating PLK1 and serves as a therapeutic target.
    Chen M; Zhang S; Wang F; He J; Jiang W; Zhang L
    J Transl Med; 2024 Feb; 22(1):209. PubMed ID: 38414025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated bioinformatics analysis reveals CDK1 and PLK1 as potential therapeutic targets of lung adenocarcinoma.
    Li S; Li H; Cao Y; Geng H; Ren F; Li K; Dai C; Li N
    Medicine (Baltimore); 2021 Aug; 100(32):e26474. PubMed ID: 34397869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Independent Prognostic Potential of GNPNAT1 in Lung Adenocarcinoma.
    Zheng X; Li Y; Ma C; Zhang J; Zhang Y; Fu Z; Luo H
    Biomed Res Int; 2020; 2020():8851437. PubMed ID: 33178836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tanshinone IIA suppresses the progression of lung adenocarcinoma through regulating CCNA2-CDK2 complex and AURKA/PLK1 pathway.
    Li Z; Zhang Y; Zhou Y; Wang F; Yin C; Ding L; Zhang S
    Sci Rep; 2021 Dec; 11(1):23681. PubMed ID: 34880385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New molecular insights into ferroptosis in lung adenocarcinoma progression and pharmacological compounds for targeted therapy.
    Tian W; Wan X; Tian L; Wu Y; Cui X; Yi J
    J Gene Med; 2024 Jan; 26(1):e3579. PubMed ID: 37581210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMMR associates with immune infiltrates and acts as a prognostic biomaker in lung adenocarcinoma.
    Ma X; Xie M; Xue Z; Yao J; Wang Y; Xue X; Wang J
    Comput Biol Med; 2022 Dec; 151(Pt A):106213. PubMed ID: 36306573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCT6A and CHCHD2 Are Coamplified with EGFR and Associated with the Unfavorable Clinical Outcomes of Lung Adenocarcinoma.
    Wang H; Wang X; Xu L; Lin Y; Zhang J
    Dis Markers; 2022; 2022():1560199. PubMed ID: 35937942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and validation of a prognostic model for lung adenocarcinoma based on endoplasmic reticulum stress-related genes.
    Li F; Niu Y; Zhao W; Yan C; Qi Y
    Sci Rep; 2022 Nov; 12(1):19857. PubMed ID: 36400857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PLK1 Is a Potential Prognostic Factor Associated with the Tumor Microenvironment in Lung Adenocarcinoma.
    Wang L; Gao M; Sun D; Wu H; Lv S; Li Y; Li L
    Biomed Res Int; 2022; 2022():7848771. PubMed ID: 35941968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel ferroptosis-related genes model for prognosis prediction of lung adenocarcinoma.
    Li F; Ge D; Sun SL
    BMC Pulm Med; 2021 Jul; 21(1):229. PubMed ID: 34256754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of CCT3 predicts poor prognosis and promotes cell proliferation via inhibition of ferroptosis and activation of AKT signaling in lung adenocarcinoma.
    Wang K; He J; Tu C; Xu H; Zhang X; Lv Y; Song C
    BMC Mol Cell Biol; 2022 Jun; 23(1):25. PubMed ID: 35773623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of Fatty Acid Metabolism in Lung Adenocarcinoma to Guide Clinical Treatment.
    Huang D; Tang E; Zhang T; Xu G
    Front Immunol; 2022; 13():916284. PubMed ID: 35860256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated analyzes identify CCT3 as a modulator to shape immunosuppressive tumor microenvironment in lung adenocarcinoma.
    Huang J; Hu B; Yang Y; Liu H; Fan X; Zhou J; Chen L
    BMC Cancer; 2023 Mar; 23(1):241. PubMed ID: 36918801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification Six Metabolic Genes as Potential Biomarkers for Lung Adenocarcinoma.
    Zhang S; Lu Y; Liu Z; Li X; Wang Z; Cai Z
    J Comput Biol; 2020 Oct; 27(10):1532-1543. PubMed ID: 32298601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel ferroptosis-related gene signature for prognostic prediction of patients with lung adenocarcinoma.
    Jin J; Liu C; Yu S; Cai L; Sitrakiniaina A; Gu R; Li W; Wu F; Xue X
    Aging (Albany NY); 2021 Jun; 13(12):16144-16164. PubMed ID: 34115610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of Ferroptosis in Lung Adenocarcinoma.
    Wei X; Li X; Hu S; Cheng J; Cai R
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of the autophagy-dependent ferroptosis-related gene FANCD2 in lung adenocarcinoma.
    Miao H; Ren Q; Li H; Zeng M; Chen D; Xu C; Chen Y; Wen Z
    BMC Cancer; 2022 Mar; 22(1):225. PubMed ID: 35236309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential role of glucosamine-phosphate N-acetyltransferase 1 in the development of lung adenocarcinoma.
    Zhang S; Zhang H; Li H; Guo J; Wang J; Zhang L
    Aging (Albany NY); 2021 Mar; 13(5):7430-7453. PubMed ID: 33686019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of prognostic model based on immunotherapy related genes in lung adenocarcinoma.
    Zhang P; Wang W; Liu L; Li H; Sha X; Wang S; Huang Z; Zhou Y; Shi J
    Sci Rep; 2022 Dec; 12(1):22077. PubMed ID: 36543847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.